India plans to vaccinate over 200 million people by July 2021

India has said that the final trails of indigenous vaccine could end in another 2 months. Covaxin, the vaccine candidate developed by Bharat Biotech India Limited (BBIL) in collaboration with Indian ICMR, has received approvals from DCGI's. Expert Committee has given the approval of the final and Phase III clinical trials.